Dr. Chaim Kabalkin, MD

Dr. Kabalkin practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Kabalkin's NPI, 1821048471, was assigned on May 12, 2006. Dr. Kabalkin holds New York license 2061101.

Dr. Kabalkin's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Kabalkin's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Kabalkin is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Kabalkin to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kabalkin practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kabalkin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kabalkin is licensed in New York.

CMS data shows 2,190 Medicare services from Dr. Kabalkin across 16 procedure codes in 2024, for 694 Medicare patients. Medicare paid $134,801 for them. Every service was in an office.

CMS counts 694 Medicare patients who saw Dr. Kabalkin in 2024. The largest group is 75 to 84, with 316 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kabalkin's median patient age at 67, with 53% women.

In 2024, Dr. Kabalkin wrote 6,625 Medicare Part D claims for 535 patients. 78% of them were for generic drugs. CMS names the drug for 6,317 of them, across 68 drugs with 11 or more claims each, at $944,287 in total drug cost. In 2023, CMS named 6,177 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kabalkin for performance year 2024, reported as part of a group. Dr. Kabalkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kabalkin as offering telehealth.

Dmand AI links 1 paper to Dr. Kabalkin. Dr. Kabalkin's most frequent co-authors are Preeti Abhinav Chandra, MD, Manali Pednekar, MD and Jacob Shani, MD.

CMS Open Payments shows 366 general payments to Dr. Kabalkin from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Merck Sharp & Dohme Corporation paid the most, $798.